Therapeutically, targeting key nodes in the browning pathway-such as β-blockers for inhibiting the adrenergic pathway, IL-6 inhibitors for mitigating inflammation-driven browning, or haemodialysis for clearing excess natriuretic peptides-may offer novel approaches to alleviate sepsis-related hypermetabolism and organ damage. This evidence concerns the gene IL6 and Sepsis.